Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
A patient begins by completing an online health intake similar in structure to Amazon's pre-visit screening but optimized for asynchronous review rather than in-person consultation
The VERTIS trial, involving 8246 patients with T2DM, compared ertugliflozin 5 mg or 15 mg daily to placebo for 3.5 years
More targets means more metabolic pathways activated, which translates to better results
In addition to a heightened risk of pancreatitis and gallstones, patients have also suffered from: Severe and Prolonged Vomiting While nausea and occasional vomiting are common side effects of GLP-1 agonists, some patients experience frequent vomiting that lasts for two weeks or more
